New injectable filler shows promise for treating diabetic wounds

Researchers at the Terasaki Institute for Biomedical Innovation have created a new injectable filler that may improve treatment for diabetic wounds. This filler uses porous microspheres made from biocompatible materials, allowing for a minimally invasive application. The study, published in ACS Nano, highlights the filler’s ability to enhance cell migration, tissue formation, and blood vessel growth. These advancements could lead to better healing outcomes compared to current treatments. The team plans to conduct further studies to move this technology toward clinical trials. The research is funded by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases.